The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bayer; Merck Serono
Consulting or Advisory Role - Bayer; Merck Serono
Research Funding - Merck Serono
Phase 2 of intra-arterial hepatic (IAH) bevacizumab with systemic chemotherapy (CT) in second line treatment of liver metastases of colorectal cancer (LMCRC).
 
Michel Ducreux
Employment - Sandoz (I)
Honoraria - Amgen; Celgene; Lilly; Merck Serono; Novartis; Roche/Genentech; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Celgene; Ipsen; Lilly; Merck Serono; Novartis; Roche/Genentech; Roche/Genentech (Inst); Sanofi; SERVIER
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche/Genentech
 
Olivier Glehen
No Relationships to Disclose
 
Gabrielle Tergemina-Clain
No Relationships to Disclose
 
Denis Michel Smith
No Relationships to Disclose
 
Benjamin Lacas
No Relationships to Disclose
 
Valerie Boige
No Relationships to Disclose
 
Guillaume Passot
No Relationships to Disclose
 
David Malka
Honoraria - Amgen; Bayer; Celgene; Lilly; Merck Serono; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Roche
 
Jean-Pierre Pignon
Research Funding - Bayer (Inst)
 
Eric Dupont-Bierre
No Relationships to Disclose
 
Rosine Guimbaud
No Relationships to Disclose